KEZAR LIFE SCIENCES INC (KZR) Stock Analyst Earnings Estimates
NASDAQ:KZR - Nasdaq - US49372L2097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7M | -100.00% | 13.13M | 46.965M 257.69% | 182.52M 288.63% | 280.74M 53.81% | |||||||
| EBITDA YoY % growth | -53.15M -28.35% | -70.14M -31.97% | -104.171M -48.52% | N/A 15.43% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -54.66M -27.26% | -71.16M -30.19% | -105.237M -47.89% | -92.676M 15.30% | -78.81M 11.58% | -85.328M -8.27% | -84.827M 0.59% | -102.384M -20.70% | -111.353M -8.76% | -85.85M 22.90% | 71.986M 183.85% | 164.97M 129.17% | |
| Operating Margin | N/A | N/A | -1,503.39% | N/A | N/A | N/A | N/A | N/A | -848.08% | -182.80% | 39.44% | 58.76% | |
| EPS YoY % growth | -1.03 -6.19% | -1.01 1.94% | -1.41 -39.60% | -6.17 -697.87% | -8.35 25.79% | -6.77 18.92% | -6.31 6.78% | -6.78 -7.48% | -2.78 59.05% | -1.14 58.91% | 3.04 366.37% | 6.70 120.27% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.41 10.65% | -2.15 22.52% | -1.78 35.68% | -1.81 20.13% | -2.96 -22.66% | -3.03 -40.67% | -3.11 -74.60% |
| Revenue Q2Q % growth | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.758M 9.78% | -19.526M 11.03% | -18.926M 12.28% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -2.27 24.33% | -2.63 | 0.36 | 13.72% |
| Q4 2024 Q2Q % growth | -2.77 -529.55% | -2.91 | 0.14 | 4.91% |
| Q3 2024 Q2Q % growth | -2.78 -768.75% | -3.18 | 0.40 | 12.62% |
| Q2 2024 Q2Q % growth | -2.70 -694.12% | -3.24 | 0.54 | 16.56% |
| Q1 2024 Q2Q % growth | -3.00 -867.74% | -3.36 | 0.36 | 10.76% |
| Q4 2023 Q2Q % growth | -0.44 -76.00% | -0.38 | -0.06 | -14.70% |
| Q3 2023 Q2Q % growth | -0.32 -28.00% | -0.35 | 0.03 | 9.26% |
| Q2 2023 Q2Q % growth | -0.34 -36.00% | -0.32 | -0.02 | -5.20% |
| Q1 2023 Q2Q % growth | -0.31 -19.23% | -0.29 | -0.02 | -6.45% |
| Q4 2022 Q2Q % growth | -0.25 | -0.28 | 0.03 | 10.48% |
| Q3 2022 Q2Q % growth | -0.25 10.71% | -0.27 | 0.02 | 8.38% |
| Q2 2022 Q2Q % growth | -0.25 | -0.28 | 0.03 | 9.94% |
| Q1 2022 Q2Q % growth | -0.26 -4.00% | -0.29 | 0.03 | 8.93% |
| Q4 2021 Q2Q % growth | -0.25 -13.64% | -0.30 | 0.05 | 16.57% |
| Q3 2021 Q2Q % growth | -0.28 -21.74% | -0.27 | -0.01 | -5.28% |
| Q2 2021 Q2Q % growth | -0.25 -13.64% | -0.26 | 0.01 | 4.80% |
| Q1 2021 Q2Q % growth | -0.25 16.67% | -0.24 | -0.01 | -4.88% |
| Q4 2020 Q2Q % growth | -0.22 56.00% | -0.23 | 0.01 | 5.46% |
| Q3 2020 Q2Q % growth | -0.23 52.08% | -0.21 | -0.02 | -9.48% |
| Q2 2020 Q2Q % growth | -0.22 52.17% | -0.27 | 0.05 | 17.49% |
| Q1 2020 Q2Q % growth | -0.30 25.00% | -0.38 | 0.08 | 20.67% |
| Q4 2019 Q2Q % growth | -0.50 | -0.55 | 0.05 | 8.63% |
| Q3 2019 Q2Q % growth | -0.48 | -0.52 | 0.04 | 7.54% |
| Q2 2019 Q2Q % growth | -0.46 | -0.48 | 0.02 | 4.32% |
| Q1 2019 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 808K | -808K | -100.00% |
| Q2 2024 Q2Q % growth | 757.5K | -757.5K | -100.00% | |
| Q1 2024 Q2Q % growth | 404K | -404K | -100.00% | |
| Q3 2023 Q2Q % growth | 7M | 84.163K | 6.916M | 8,217.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 9.36% |
| Revenue | N/A | N/A | N/A | N/A |